Frequency and phenotype of circulating Vα24/Vβ11 double-positive natural killer T cells during hepatitis C virus infection

Journal of Virology

Volumn 77, Issue 3, 2003, Pages 2251-2257

  Lucas, Michaela ^a   Gadola, Stephan ^a   Meier, Ute ^c   Young, Neil T ^b   Harcourt, Gillian ^a   Karadimitris, Anastasios ^a   Coumi, Nikki ^a   Brown, Dave ^d   Dusheiko, Geoff ^d   Cerundolo, Vincenzo ^a   Klenerman, Paul ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c EDWARD JENNER INST FOR VACC RES   (United Kingdom)

^d ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY SPECIFICITY; ARTICLE; BLOOD SAMPLING; CELLULAR IMMUNITY; COHORT ANALYSIS; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LYMPHOCYTE SUBPOPULATION; MONONUCLEAR CELL; NATURAL KILLER CELL; PERSISTENT VIRUS INFECTION; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VIRUS DETECTION;

ANTIGENS, CD; ANTIGENS, CD3; ANTIGENS, CD56; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; HEPATITIS C; HUMANS; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTE SUBSETS;

EID: 0037302303     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.3.2251-2257.2003     Document Type: Article

References (32)

1. Baron, J. L., L. Gardiner, S. Nishimura, K. Shinkai, R. Locksley, and D. Ganem. 2002. Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection. Immunity 16:583-594.
2. Benlagha, K., A. Weiss, A. Beavis, L. Teyton, and A. Bendelac. 2000. In vivo identification of glycolipid antigen-specific T cells using fluorescent CDld tetramers. J. Exp. Med. 191:1895-1903.
3. Carnaud, C., D. Lee, O. Donnars, S. H. Park, A. Beavis, Y. Koezuka, and A. Bendelac. 1999. Cutting edge: cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J. Immunol. 163:4647-4650.
4. Chang, K. M., B. Rehermann, and F. V. Chisari. 1997. Immunopathology of hepatitis C. Springer Semin. Immunopathol. 19:57-68.
5. + T cells produce large amounts of IL-4 and IFN-gamma upon activation by anti-CD3 or CD1. J. Immunol. 159:2240-2249.
6. + natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns. J. Immunol 163:2314-2321.
7. Dunne, J., S. Lynch, C. O'Farrelly, S. Todryk, J. E. Hegarty, C. Feighery, and D. G. Doherty. 2001. Selective expansion and partial activation of human NK cells and NK receptor-positive T cells by IL-2 and IL-15. J. Immunol. 167: 3129-3138.
8. Exley, M. A., Q. He, O. Cheng, R. J. Wang, C. P. Cheney, S. P. Balk, and M. J. Koziel. 2002. Cutting edge: compartmentalization of Th1-like noninvariant CDld-reactive T cells in hepatitis C virus-infected liver. J. Immunol. 168:1519-1523.
9. + and CD8αβ T lymphocytes. J. Immunol. 168:5514-5520.
10. Godfrey, D.I., K. J. Hammond, L. D. Poulton, M. J. Smyth, and A. G. Baxter. 2000. NKT cells: facts, functions and fallacies. Immunol. Today 21:573-583.
11. Grabowska, A. M., F. Lechner, P. Klenerman, P. J. Tighe, S. Ryder, J. K. Ball, B. J. Thomson, W. L. Irving, and R. A. Robins. 2001. Direct ex vivo comparison of the breadth and specificity of the T cells in the liver and peripheral blood of patients with chronic HCV infection. Eur. J. Immunol. 31:2388-2394.
12. Jin, Y., L. Fuller, M. Carreno, K. Zucker, D. Roth, V. Esquenazi, T. Karatzas, S. J. Swanson III, A. G. Tzakis, and J. Miller. 1997. The immune reactivity role of HCV-induced liver infiltrating lymphoeytes in hepatocellular damage. J. Clin. Immunol, 17:140-153.
13. Kakimi, K., L. G. Guidotti, Y. Koezuka, and F. V. Chisari. 2000. Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J. Exp. Med. 192:921-930.
14. Karadimitris, A., S. Gadola, M. Altamirano, D. Brown, A. Woolfson, P. Klenerman, J. L. Chen, Y. Koezuka, I. A. Roberts, D. A. Price, G. Dusheiko, C. Milstein, A. Fersht, L. Luzzatto, and V. Cerundolo. 2001. Human CD1d-glycolipid tetramers generated by in vitro oxidative refolding chromatography. Proc. Natl. Acad. Sci. USA 98:3294-3298.
15. Kawano, T., J. Cui, Y. Koezuka, I. Toura, Y. Kaneko, K. Motoki, H. Ueno, R. Nakagawa, H. Sato, E. Kondo, H. Koseki, and M. Taniguchi. 1997. CD1d-restricted and TCR-mediated activation of vα14 NKT cells by glycosylceramides. Science 278:1626-1629.
16. + NKT cells against melanoma. Br. J. Cancer 85:741-746.
17. Lauer, G. M., and B. D. Walker. 2001. Hepatitis C virus infection. N. Engl. J. Med. 345:41-52.
18. Lechner, F., D. K. Wong, P. R. Dunbar, R. Chapman, R. T. Chung, P. Dohrenwend, G. Robbins, R. Phillips, P. Klenerman, and B. D. Walker. 2000. Analysis of successful immune responses in persons infected with hepatitis C virus. J. Exp. Med. 191:1499-1512.
19. Matsuda, J. L., O. V. Naidenko, L. Gapin, T. Nakayama, M. Taniguchi, C. R. Wang, Y. Koezuka, and M. Kronenberg. 2000. Tracking the response of natural killer T cells to a glycolipid antigen using CDld tetramers. J. Exp. Med. 192:741-754.
20. Motsinger, A., D. W. Haas, A. K. Stanic, L. Van Kaer, S. Joyce, and D. Unutmaz. 2002. CDld-restricted human natural killer T cells are highly susceptible to human immunodeficiency virus 1 infection. J. Exp. Med. 195: 869-879.
21. + T cells and rapid elimination of effector cells by apoptosis. Eur. J. Immunol. 28:3448-3455.
22. - T cells bearing invariant Vα24JαQ TCR α-chain are decreased in patients with atopic diseases. Clin. Exp. Immunol. 119:404-411.
23. Oishi, Y., T. Sumida, A. Sakamoto, Y. Kita, K. Kurasawa, Y. Nawata, K. Takabayashi, H. Takahashi, S. Yoshida, M. Taniguchi, Y. Saito, and I. Iwamoto. 2001. Selective reduction and recovery of invariant Vα24JαQ T cell receptor T cells in correlation with disease activity in patients with systemic lupus erythematosus. J. Rheumatol. 28:275-283.
24. + Vα24 natural killer T cells in human immunodeficiency virus infection. J. Virol. 76:7528-7534.
25. Seino, K. I., K. Fukao, K. Muramoto, K. Yanagisawa, Y. Takada, S. Kakuta, Y. Iwakura, L. Van Kaer, K. Takeda, T. Nakayama, M. Taniguchi, H. Bashuda, H. Yagita, and K. Okumura. 2001. Requirement for natural killer T (NKT) cells in the induction of allograft tolerance. Proc. Natl. Acad. Sci. USA 98:2577-2581.
26. Smyth, M. J., N. Y. Crowe, Y. Hayakawa, K. Takeda, H. Yagita, and D. I. Godfrey. 2002. NKT cells - conductors of tumor immunity? Curr. Opin. Immunol. 14:165-171.
27. + NK T cells activated by alpha-galactosytceramide-pulsed monocyte-derived dendritic cells. J. Immunol 168:3140-3144.
28. Takeda, K., Y. Hayakawa, L. Van Kaer, H. Matsuda, H. Yagita, and K. Okumura. 2000. Critical contribution of liver natural killer T cells to a murine model of hepatitis. Proc. Natl. Acad. Sci. USA 97:5498-5503.
29. Taniguchi, M., and T. Nakayama. 2000. Recognition and function of Vα14 NKT cells. Semin. Immunol. 12:543-550.
30. Valiante, N. M., A. D'Andrea, S. Crotta, F. Lechner, P. Klenerman, S. Nuti, A. Wack, and S. Abrignani. 2000. Life, activation and death of intrahepatic lymphocytes in chronic hepatitis C. Immunol. Rev. 174:77-89.
31. van der Vliet, H. J., N. Nishi, Y. Koezuka, B. M. von Blomberg, A. J. van den Eertwegh, S. A. Porcelli, H. M. Pinedo, R. J. Scheper, and G. Giaccone. 2001. Potent expansion of human natural killer T cells using alpha-galactosylceramide (KRN7000)-loaded monocyte-derived dendritic cells, cultured in the presence of IL-7 and IL-15. J. Immunol. Methods 247:61-72.
32. + NKT cells during HIV type 1 infection. J. Immunol 168:1490-1495.